Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jun 2024 for Marinus Pharmaceuticals, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sara Nochur: trading record in brief
Sara Nochur (board member) discloses dealings in 2 companies, chiefly Marinus Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. The record holds 6 filings, for trades running from 4 February 2022 to 18 June 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 20 June 2024 came the latest disclosure, a share grant in Marinus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sara Nochur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,300 shares0Common StockSEC:0001415889-24-017638:0
4,600 shares0Common StockSEC:0001415889-24-001597:0
5,000 sharesCommon StockSEC:0000899243-23-019487:0
5,000 shares0Common StockSEC:0000950170-23-027998:0
3,600 shares0Common StockSEC:0001415889-23-001550:0
2,750 shares0Common StockSEC:0001104659-22-012792:0
6 of 6 declarations
